With its trials and pricing set, Pfizer has pulled back the curtain on the long-range commercial strategy for its COVID-19 vaccine. During its earnings call Tuesday, execs laid out two phases, pandemic and seasonal, with some combination of the two likely to play out over the next several years. The current pandemic phase, expected to continue… Read More »
Compared with the general population, inmates experience an almost sixfold greater risk of contracting COVID-19 as well as a threefold higher risk of dying of the severe respiratory condition, suggest new findings published in the journal JAMA by researchers at Johns Hopkins Bloomberg School of Public Health. For the recent study, scientists counted the number… Read More »
Coronavirus has wreaked havoc after affecting more than five million people over the world. More than 12.4 M million coronavirus cases have been reported worldwide. According to WorldMeter data, the number of corona positive has reached 12,675,441, and 563,928 people have died due to the epidemic. Corona havoc is not only causing death, but it… Read More »
Email Tweet Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19. Jun 30 2020 Aruna Subramanian is investigating an antiviral drug, favipiravir, to see if it reduces symptoms and viral shedding… Read More »